URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORS

The present invention provides compounds of Formula I or pharmaceutically acceptable salt forms thereof, wherein R a , R b , R c , R d , D, W, R 1a , R 1b , R 1c , Y, R 3 , X, E and G are as defined herein, and uses as AXL and c-MET kinase inhibitors .

Saved in:
Bibliographic Details
Main Authors PROUTY Catherine P, HUDKINS Robert L, TRIPATHY Rabindranath, DANDU Reddeppareddy, JOSEF Kurt A
Format Patent
LanguageEnglish
Slovenian
Published 26.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides compounds of Formula I or pharmaceutically acceptable salt forms thereof, wherein R a , R b , R c , R d , D, W, R 1a , R 1b , R 1c , Y, R 3 , X, E and G are as defined herein, and uses as AXL and c-MET kinase inhibitors .
AbstractList The present invention provides compounds of Formula I or pharmaceutically acceptable salt forms thereof, wherein R a , R b , R c , R d , D, W, R 1a , R 1b , R 1c , Y, R 3 , X, E and G are as defined herein, and uses as AXL and c-MET kinase inhibitors .
Author HUDKINS Robert L
DANDU Reddeppareddy
JOSEF Kurt A
PROUTY Catherine P
TRIPATHY Rabindranath
Author_xml – fullname: PROUTY Catherine P
– fullname: HUDKINS Robert L
– fullname: TRIPATHY Rabindranath
– fullname: DANDU Reddeppareddy
– fullname: JOSEF Kurt A
BookMark eNrjYmDJy89L5WQwDQ1ydPb0UXBxDfIMcwzxDHMNVnAEoggfBUc_FwVnXV_XEAVvTz_HYFcFTz8PTyfPEP-gYB4G1rTEnOJUXijNzaDo5hri7KGbWpAfn1pckJicmpdaEh_saWRuYWBsbBESYmhMjBoA1wspnA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate URACILNI DERIVATI KOT ZAVIRALCI AXL IN C-MET KINAZE
ExternalDocumentID SI2780338TT1
GroupedDBID EVB
ID FETCH-epo_espacenet_SI2780338TT13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:55:08 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Slovenian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_SI2780338TT13
Notes Application Number: SI20120030843
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170426&DB=EPODOC&CC=SI&NR=2780338T1
ParticipantIDs epo_espacenet_SI2780338TT1
PublicationCentury 2000
PublicationDate 20170426
PublicationDateYYYYMMDD 2017-04-26
PublicationDate_xml – month: 04
  year: 2017
  text: 20170426
  day: 26
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies Ignyta, Inc
RelatedCompanies_xml – name: Ignyta, Inc
Score 3.0838087
Snippet The present invention provides compounds of Formula I or pharmaceutically acceptable salt forms thereof, wherein R a , R b , R c , R d , D, W, R 1a , R 1b , R...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170426&DB=EPODOC&locale=&CC=SI&NR=2780338T1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp6LzgwjSt-K2rh97KNKlHYts3VizsbeRpikMZBuu4r_vpW7qi0IeQgKX5OBy-eVyvwA8Wm4rF15HmU5mKbMtM2kKYUvTyy3ppbJhiS-2z9jpT9svc3tegeU-F6bkCf0oyRHRoiTae1Hu15ufS6ywfFu5fUqX2LR-7nE_NHbouOlqSGCEXT8aj8IRNSj1E2bEE7_leg1EYxyB0oE-RWua_WjW1Ukpm98epXcKh2MUtirOoLJ9rcEx3X-8VoOj4S7ejdWd6W3PwZ5OAsoGJETkNQs4m0UJCbDMBySIQ0LNYcQJYvEgiQiL-6zL-GiSXMBDL-K0b-L4i--1LhK2nylvWpdQXa1X6gpIZuWq2RHCzVXadhxbaKaxTLlennfwACOvof63nPp_nTdwovWmAyQt5xaqxdu7ukM_W6T3pYY-AWzjfg0
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da8IwED_Ejbm3zW1M95XB6FuZWvvhQxk1rTRbrWKj-CZpmoIwVGbH_v0lnW572SAPIYFLcnC5_HK5XwAeDLuTM6cndCszhN7lGdcZM7nu5AZ3Ut4y2BfbZ2yF0-7z3JxXYLnPhSl5Qj9KckRpUVzae1Hu15ufSyy_fFu5fUyXsmn9NKCur-3QcdtWkEDz-24wHvkjrGHsJkSLJ27HdloSjVEJlA5sRc6rTk6zvkpK2fz2KIMTOBxLYaviFCrb1zrU8P7jtTocDXfxblndmd72DMzpxMMkQr5EXjOPklmQIE-WeYS82EdYHwYUSSzuJQEicUj6hI4myTncDwKKQ12Ov_he6yIh-5nStnEB1dV6JS4BZUYu2j3G7FykXcsymWIay4Tt5HlPHmB4A5p_y2n-13kHtZAOo0VE4pcrOFY6VMGSjnUN1eLtXdxIn1ukt6W2PgF6DID6
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=URACIL+DERIVATIVES+AS+AXL+AND+C-MET+KINASE+INHIBITORS&rft.inventor=PROUTY+Catherine+P&rft.inventor=HUDKINS+Robert+L&rft.inventor=TRIPATHY+Rabindranath&rft.inventor=DANDU+Reddeppareddy&rft.inventor=JOSEF+Kurt+A&rft.date=2017-04-26&rft.externalDBID=T1&rft.externalDocID=SI2780338TT1